go Contents

R&D Information / Keeping in mind our commitment to respect to respect life and for a health future for INFO all of mankind, SAMA is bolstering its capabilities outside of Korea.

R&D

  • KGMP factory movie : State-of-the art clean area EU Standard KGMP factory to introduce

R&D Status

HOME R&D R&D Status

SAMA Pharmaceutical's future development strategy

focuses on strengthening global competitiveness.

Development stage
Subject Project Project Description Development stage
NME(New Molecular Entity) SA09012 Leukotriene receptor antagonist
for Bronchial asthma		 Phase II
(on-going)
IDIA™(Instant Dissolving
Immediate Absorption)		 VIASIN
gran.		 the world’s first granule
formulation of Sildenafil		 Launched
IMD(Incrementally
Modified Drug)		 CITUS dry syr. New Indication
(Perennial Allergic Rhinitis)		 Launched
CITUS Dispersible tab. New formulation
(Improving Drug compliance)		 Launched
CAMODIX Dispersible tab. New formulation
(Improving Drug compliance)		 Launched
HEBRON-F tab. New formulation
(Improving Drug compliance)		 Launched
ROXIGRAN gran. New formulation
(Improving Drug compliance)		 Launched
DOMPERIDONE gran. New formulation
(Improving Drug compliance)		 Launched
SETOPEN dry syr. New formulation
(Improving Drug compliance)		 Launched